{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:33:25Z","timestamp":1782282805869,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.rmed.2016.01.016","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T05:13:37Z","timestamp":1454044417000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The generalizability of bronchiectasis randomized controlled trials: A multicentre cohort study"],"prefix":"10.1016","volume":"112","author":[{"given":"James D.","family":"Chalmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Finch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Crichton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Fardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"De Soyza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6220-2220","authenticated-orcid":false,"given":"Pieter","family":"Goeminne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.rmed.2016.01.016_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S2213-2600(14)70274-7","article-title":"Non-cystic fibrosis bronchiectasis: an evidence base for new therapies","volume":"2","author":"Bilton","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2016.01.016_bib2","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1183\/09031936.00119114","article-title":"State of the Art: Management of Bronchiectasis in adults","volume":"45","author":"Chalmers","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2016.01.016_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201005-0756OC","article-title":"A\u00a0randomised controlled trial of nebulised gentamicin in non-cystic fibrosis bronchiectasis","volume":"183","author":"Murray","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.rmed.2016.01.016_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.rmed.2016.01.016_bib5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2016.01.016_bib6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1183\/09031936.00071312","article-title":"Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study","volume":"41","author":"Wilson","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.rmed.2016.01.016_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","article-title":"Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial","volume":"68","author":"Serisier","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2016.01.016_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1378\/chest.12-1763","article-title":"Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis","volume":"144","author":"Bilton","year":"2013","journal-title":"Chest"},{"issue":"suppl. 1","key":"10.1016\/j.rmed.2016.01.016_bib9","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2016.01.016_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2010.03.020","article-title":"Patients included in randomised controlled trials do not represent those seen in clinical practice: focus on antimicrobial agents","volume":"36","author":"Falagas","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.rmed.2016.01.016_bib11","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1161\/STROKEAHA.109.551812","article-title":"Patients enrolled in large randomized clinical trials of anti-platelet treatment for prevention after transient ischemic attack or ischaemic stroke are not representative of patients in clinical practice","volume":"40","author":"Maasland","year":"2009","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.rmed.2016.01.016_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.rmed.2004.03.026","article-title":"How representative are clinical study patients with asthma or COPD for a larger \u201creal life\u201d population of patients with obstructive lung disease","volume":"99","author":"Herland","year":"2005","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2016.01.016_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"Derivation and validation of the bronchiectasis severity index: an international multicentre observational study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2016.01.016_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2016.01.016_bib15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"Pasteur","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2016.01.016_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2012.09.011","article-title":"Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis","volume":"55","author":"Chalmers","year":"2013","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.rmed.2016.01.016_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance","volume":"109","author":"McDonnell","year":"2014","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2016.01.016_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thoraxjnl-2012-202125","article-title":"Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in non-CF bronchiectasis","volume":"68","author":"Chalmers","year":"2012","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2016.01.016_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2016.01.016_bib20","first-page":"261","article-title":"CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types","volume":"165","author":"Reiff","year":"1995","journal-title":"A.\u00a0J. R."},{"issue":"10","key":"10.1016\/j.rmed.2016.01.016_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/thoraxjnl-2012-201983","article-title":"British Thoracic Society national bronchiectasis audit 2010 and 2011","volume":"67","author":"Hill","year":"2012","journal-title":"Thorax"},{"issue":"9842","key":"10.1016\/j.rmed.2016.01.016_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2016.01.016_bib23","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2016.01.016_bib24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"issue":"2 pt 1","key":"10.1016\/j.rmed.2016.01.016_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. Georges Respiratory Questionnaire in bronchiectasis","volume":"156","author":"Wilson","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2016.01.016_bib27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmed.2016.01.016_bib28","first-page":"1602","article-title":"A\u00a0comprehensive analysis of the impact of Pseudomonas aeruginosa on outcomes in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"6","key":"10.1016\/j.rmed.2016.01.016_bib29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.rmed.2006.11.008","article-title":"Aetiology in adult patients with bronchiectasis","volume":"101","author":"Shoemark","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2016.01.016_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00081-2015","article-title":"The European Bronchiectasis Registry (EMBARC) Protocol for an international observational study","volume":"2","author":"Chalmers","year":"2016","journal-title":"ERJ Open Res."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116300129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116300129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:33:29Z","timestamp":1760614409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611116300129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":29,"alternative-id":["S0954611116300129"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.01.016","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The generalizability of bronchiectasis randomized controlled trials: A multicentre cohort study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}